CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Nature Immunology

• Publication date

  2001-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/90675PMID 11477410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemokines and their receptors in infectious disease

  2009cited by this paper
• Human Cytomegalovirus Chemokine Receptor Gene US28 Is Transcribed in Latently Infected THP-1 Monocytes

  2001cited by this paper
• Chemokines and their receptors in lymphocyte traffic and HIV infection.

  2000cited by this paper
• Purification of respiratory syncytial virus F and G proteins.

  2000cited by this paper
• Respiratory Syncytial Virus G and/or SH Glycoproteins Modify CC and CXC Chemokine mRNA Expression in the BALB/c Mouse

  2000cited by this paper
• Respiratory Syncytial Virus Infection and G and/or SH Protein Expression Contribute to Substance P, Which Mediates Inflammation and Enhanced Pulmonary Disease in BALB/c Mice

  2000cited by this paper
• Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.

  2000cited by this paper
• The Fusion Glycoprotein of Human Respiratory Syncytial Virus Facilitates Virus Attachment and Infectivity via an Interaction with Cellular Heparan Sulfate

  2000cited by this paper
• Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

  2000cited by this paper
• Structure and Function of the Glycosaminoglycan Binding Site of Chemokine Macrophage-Inflammatory Protein-1β

  1999cited by this paper
• The Kaposi's Sarcoma–related Herpesvirus (KSHV)-encoded Chemokine vMIP-I is a Specific Agonist for the CC Chemokine Receptor (CCR)8

  1999cited by this paper
• Respiratory syncytial virus: A continuing culprit and conundrum.

  1999cited by this paper
• Identification of a Linear Heparin Binding Domain for Human Respiratory Syncytial Virus Attachment Glycoprotein G

  1999cited by this paper
• Respiratory Syncytial Virus G and/or SH Protein Alters Th1 Cytokines, Natural Killer Cells, and Neutrophils Responding to Pulmonary Infection in BALB/c Mice

  1999cited by this paper
• Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1 beta.

  1999cited by this paper
• Chemokine receptor trafficking and viral replication

  1999cited by this paper
• Priming with Secreted Glycoprotein G of Respiratory Syncytial Virus (RSV) Augments Interleukin-5 Production and Tissue Eosinophilia after RSV Challenge

  1998cited by this paper
• Eliminating a Region of Respiratory Syncytial Virus Attachment Protein Allows Induction of Protective Immunity without Vaccine-enhanced Lung Eosinophilia

  1998cited by this paper
• Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine.

  1998cited by this paper
• Atypical Pulmonary Eosinophilia Is Mediated by a Specific Amino Acid Sequence of the Attachment (G) Protein of Respiratory Syncytial Virus

  1998cited by this paper
• Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow

  1998cited by this paper
• Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1.

  1998cited by this paper
• Heparin-Like Structures on Respiratory Syncytial Virus Are Involved in Its Infectivity In Vitro

  1998cited by this paper
• Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia.

  1998cited by this paper
• Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection

  1997cited by this paper
• Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

  1997cited by this paper
• The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines

  1997cited by this paper
• Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein.

  1997cited by this paper
• Fractalkine--a strange attractor in the chemokine landscape.

  1997cited by this paper
• Respiratory syncytial virus infection in children with congenital heart disease: A review

  1996cited by this paper
• Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus

  1996cited by this paper
• Immunity and immunopathology to respiratory syncytial virus. The mouse model.

  1995cited by this paper
• Comparison of the T helper cell response induced by respiratory syncytial virus and its fusion protein in BALB/c mice.

  1995cited by this paper
• Resiniferatoxin binding to vanilloid receptors in guinea pig and human airways.

  1995cited by this paper
• Antigenic analysis of chimeric and truncated G proteins of respiratory syncytial virus.

  1995cited by this paper
• Macrophage inflammatory proteins: biology and role in pulmonary inflammation.

  1994cited by this paper
• Differential binding of chemokines to glycosaminoglycan subpopulations.

  1994cited by this paper
• Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.

  1993cited by this paper
• Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunization.

  1992cited by this paper
• Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived

  1991cited by this paper
• Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus

  1987cited by this paper
• The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.

  1987cited by this paper
• Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.

  1986cited by this paper
• Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.

  1985cited by this paper
• Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus.

  1980cited by this paper
• Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population.

  1969cited by this paper
• Respiratory virus vaccines. V. Field evaluation for efficacy of heptavalent vaccine.

  1966cited by this paper
• THE CHEMOTACTIC EFFECT OF MIXTURES OF ANTIBODY AND ANTIGEN ON POLYMORPHONUCLEAR LEUCOCYTES

  1962cited by this paper
• A Review of the

  year unknowncited by this paper

• The soluble G protein of respiratory syncytial virus promotes viral dissemination via TLR2-mediated NLRP3 priming and pyroptosis

  2026influential citation
• Internalization-related host factors of common respiratory viruses

  2026cites this paper
• Host-pathogen interaction in community-acquired pneumonia: a focus on the immune response.

  2026cites this paper
• Secretory Expression and Purification of Respiratory Syncytial Virus G and F Ectodomain in Human Cells.

  2025cites this paper
• Exploring Therapeutic Targets From Spreading Patterns Against Respiratory Syncytial Virus

  2025cites this paper
• Respiratory syncytial virus fuses with plasma membrane to infect primary cultures of bronchial epithelial cells

  2025cites this paper
• Chemokine (C-X-C motif) ligand 11 is a crucial antiviral modulator that affects viral replication, the IFN-γ response, and T-cell functions during respiratory syncytial virus infection.

  2025cites this paper
• RSV Vaccines: Targeting Prefusion F and G Proteins from Structural Design to Clinical Application

  2025influential citation
• Progress on Respiratory Syncytial Virus Vaccine Development and Evaluation Methods

  2025cites this paper
• Single cell sequencing analysis of respiratory syncytial virus infected pediatric and adult human nose organoids reveals age differences, proliferative diversity and identifies novel cellular tropism.

  2025cites this paper
• Host immune response to respiratory syncytial virus infection and its contribution to protection and susceptibility in adults: a systematic literature review

  2025cites this paper
• Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles

  2025cites this paper
• Advances in development of antiviral strategies against respiratory syncytial virus

  2025influential citation
• Polybodies for the treatment of respiratory syncytial virus infection.

  2025cites this paper
• Immunomodulation in Respiratory Syncytial Virus Infection: Mechanisms, Therapeutic Targets, and Clinical Implications

  2025cites this paper
• Aptamers targeting respiratory syncytial virus showed high inhibitory activity by blocking the G protein

  2025cites this paper
• Virion stripping: A new role for bacterial proteases

  2025cites this paper
• The link between respiratory syncytial virus (RSV) morphogenesis and virus transmission: Towards a paradigm for understanding RSV transmission in the upper airway.

  2025cites this paper
• Restricting O-Linked Glycosylation of the Mucin-like Domains Enhances Immunogenicity and Protective Efficacy of a Respiratory Syncytial Virus G Glycoprotein Vaccine Antigen

  2025cites this paper
• Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Its Implications for Prophylactic and Therapeutic Pharmaceuticals

  2025cites this paper
• N6-methyladenosine modification of the subgroup J avian leukosis viral RNAs attenuates host innate immunity via MDA5 signaling

  2025cites this paper
• Current antiviral therapies and promising drug candidates against respiratory syncytial virus infection

  2025cites this paper
• Innate immune evasion and general host shutoff strategies of human respiratory RNA viruses

  2025cites this paper
• Computational Insights into the Interaction of the Conserved Cysteine-Noose Domain of the Human Respiratory Syncytial Virus G Protein with the Canonical Fractalkine Binding site of Transmembrane Receptor CX3CR1 Isoforms

  2024cites this paper
• The role of respiratory syncytial virus G protein in immune cell infection and pathogenesis

  2024cites this paper
• COVID-19 in Pediatric Populations.

  2024cites this paper
• Evolutionary trends of respiratory syncytial viruses: Insights from large-scale surveillance and molecular dynamics of G glycoprotein

  2024cites this paper
• Global progress in clinical research on human respiratory syncytial virus vaccines

  2024cites this paper
• Lethal model for respiratory syncytial virus infection using C57BL/6 mice

  2024cites this paper
• The Role of the CX3CR1-CX3CL1 Axis in Respiratory Syncytial Virus Infection and the Triggered Immune Response

  2024cites this paper
• Monoclonal antibodies targeting sites in respiratory syncytial virus attachment G protein provide protection against RSV-A and RSV-B in mice

  2024cites this paper
• KD-409, a Respiratory Syncytial Virus FG Chimeric Protein without the CX3C Chemokine Motif, Is an Efficient Respiratory Syncytial Virus Vaccine Preparation for Passive and Active Immunization in Mice

  2024cites this paper
• Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G

  2024cites this paper
• Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry via multi-targeting glycoprotein and fusion protein

  2024influential citation
• Infection of nonclassic monocytes by respiratory syncytial virus induces an imbalance in the CD4+ T-cell subset response

  2024cites this paper
• Surfactant Protein-A (SP-A) and its Immunomodulatory Roles in Infant Respiratory Syncytial Virus (RSV) Infection - a potential for therapeutic intervention?

  2024cites this paper
• Biology of human respiratory syncytial virus: Current perspectives in immune response and mechanisms against the virus

  2024influential citation
• Respiratory syncytial virus glycoprotein G impedes CX3CR1-activation by CX3CL1 and monocyte function

  2024cites this paper
• Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus

  2024cites this paper
• A complex remodeling of cellular homeostasis distinguishes RSV/SARS-CoV-2 co-infected A549-hACE2 expressing cell lines.

  2024cites this paper
• Alterations in CX3CL1 Levels and Its Role in Viral Pathogenesis

  2024cites this paper
• Host Responses to Respiratory Syncytial Virus Infection

  2023cites this paper
• Respiratory syncytial virus entry mechanism in host cells: A general overview

  2023cites this paper
• Modulation of innate immunity in airway epithelium for host-directed therapy

  2023cites this paper
• Non-glycosylated G protein with CpG ODN provides robust protection against respiratory syncytial virus without inducing eosinophilia

  2023cites this paper
• Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response

  2023cites this paper
• Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein

  2023cites this paper
• Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine

  2023cites this paper
• Biochemistry of the Respiratory Syncytial Virus L Protein Embedding RNA Polymerase and Capping Activities

  2023cites this paper
• Viral infections and chronic rhinosinusitis.

  2023cites this paper
• Responding to Higher-Than-Expected Infant Mortality Rates from Respiratory Syncytial Virus (RSV): Improving Treatment and Reporting Strategies

  2023cites this paper
• Interferons—Implications in the Immune Response to Respiratory Viruses

  2023cites this paper
• Current state and challenges in respiratory syncytial virus drug discovery and development.

  2023cites this paper
• Defining the Assembleome of the Respiratory Syncytial Virus.

  2023cites this paper
• The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate

  2023cites this paper
• The implication of infection with respiratory syncytial virus in pediatric recurrent wheezing and asthma: knowledge expanded post-COVID-19 era

  2023cites this paper
• Ephedrae Herba and Cinnamomi Cortex interactions with G glycoprotein inhibit respiratory syncytial virus infectivity

  2022cites this paper
• Mutation in the CX3C Motif of G Protein Disrupts Its Interaction with Heparan Sulfate: A Calorimetric, Spectroscopic, and Molecular Docking Study

  2022cites this paper
• How RSV Proteins Join Forces to Overcome the Host Innate Immune Response

  2022influential citation
• RSV pre-fusion F protein enhances the G protein antibody and anti-infectious responses

  2022cites this paper
• The Respiratory Syncytial Virus G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-like Particle Vaccine Candidate

  2022cites this paper
• RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein

  2022cites this paper
• Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge

  2022cites this paper
• Codon-optimization of the respiratory syncytial virus (RSV) G protein expressed in a vesicular stomatitis virus (VSV) vector improves immune responses in a cotton rat model.

  2022cites this paper
• Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens

  2022cites this paper
• Ephedrae Herba and Cinnamomi Cortex interactions with G glycoprotein inhibit respiratory syncytial virus infectivity

  2022cites this paper
• Viral Genetic Determinants of Prolonged Respiratory Syncytial Virus Infection Among Infants in a Healthy Term Birth Cohort

  2022cites this paper
• Receptors for Respiratory Syncytial Virus Infection and Host Factors Regulating the Life Cycle of Respiratory Syncytial Virus

  2022cites this paper
• Innate Immune Evasion by Human Respiratory Syncytial Virus

  2022cites this paper
• RSV disease in infants and young children: Can we see a brighter future?

  2022cites this paper
• Analysis of circulating respiratory syncytial virus A strains in Shanghai, China identified a new and increasingly prevalent lineage within the dominant ON1 genotype

  2022cites this paper
• Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV)

  2021cites this paper
• Structural Characterization and Binding Studies of the Ectodomain G Protein of Respiratory Syncytial Virus Reveal the Crucial Role of pH with Possible Implications in Host–Pathogen Interactions

  2021cites this paper
• Chemokines and Chemokine Receptors

  2021cites this paper
• Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies

  2021influential citation
• Role of CCR3 in respiratory syncytial virus infection of airway epithelial cells

  2021influential citation
• Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates

  2021cites this paper
• Synchronization Temperature Determines the Location of RSV Fusion During Entry in Cultured Cells

  2021cites this paper
• New preventive strategies for respiratory syncytial virus infection in children.

  2021cites this paper
• Immunogenicity and inflammatory properties of respiratory syncytial virus attachment G protein in cotton rats

  2021cites this paper
• Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Using Murine Models to Understand Human Pathology

  2021cites this paper
• Молекулярные и клеточные механизмы патогенеза респираторно-синцитиальной вирусной инфекции. Новые данные на экспериментальных моделях

  2021cites this paper
• Immunopathology of RSV: An Updated Review

  2021cites this paper
• Small Non-coding RNA Expression Following Respiratory Syncytial Virus or Measles Virus Infection of Neuronal Cells

  2021cites this paper
• Role of metapneumoviral glycoproteins in the evasion of the host cell innate immune response.

  2021cites this paper
• Inhibition of respiratory syncytial virus infectivity by Ephedrae Herba and Cinnamomi Cortex through interaction with G glycoprotein

  2021cites this paper
• Evolution of proteomics technologies for understanding respiratory syncytial virus pathogenesis

  2021cites this paper
• CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats

  2021cites this paper
• Current Insights into the Host Immune Response to Respiratory Viral Infections.

  2021cites this paper
• Epidemiology and genetic characterization of respiratory syncytial virus in children with acute respiratory infections: Findings from the influenza sentinel surveillance network in Central African Republic, 2015 to 2018

  2021cites this paper
• Functional Features of the Respiratory Syncytial Virus G Protein

  2021cites this paper
• Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infection

  2021cites this paper
• CX3CR1 Engagement by Respiratory Syncytial Virus Leads to Induction of Nucleolin and Dysregulation of Cilium-Related Genes

  2020cites this paper
• The Journey to an RSV Vaccine

  2020cites this paper
• Towards a unified classification for human respiratory syncytial virus genotypes

  2020cites this paper
• Up-to-date role of biologics in the management of respiratory syncytial virus

  2020cites this paper
• Antibody development for preventing the human respiratory syncytial virus pathology

  2020cites this paper
• Respiratory syncytial virus infection exacerbates pneumococcal pneumonia via Gas6/Axl-mediated macrophage polarization.

  2020cites this paper
• The Journey to an RSV Vaccine.

  2020cites this paper
• Design and Synthesis of 2-(1-Alkylaminoalkyl)pyrazolo[1,5-a]pyrimidines as New Respiratory Syncytial Virus Fusion Protein Inhibitors.

  2020cites this paper